Effectiveness of a Buteyko-based Breathing Technique for Asthma Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03098849 |
Recruitment Status :
Completed
First Posted : April 4, 2017
Last Update Posted : May 9, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Asthma | Other: Buteyko Breathing Technique | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 63 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Effectiveness of a Buteyko-based Breathing Technique on Psycho-physiological Parameters of Adults With Asthma - a Randomized, Controlled Study |
Actual Study Start Date : | January 25, 2017 |
Actual Primary Completion Date : | October 26, 2017 |
Actual Study Completion Date : | October 26, 2017 |
Arm | Intervention/treatment |
---|---|
Experimental: Buteyko Training
Breathing exercises according to the Buteyko Breathing Technique
|
Other: Buteyko Breathing Technique
Patients are trained in various exercises aiming at breath reduction and breath control as introduced by Dr. K. Buteyko |
No Intervention: Control Group
Standard care as usual
|
- Change in Endtidal CO2 [ Time Frame: Between baseline and 3 month follow up ]Capnometry
- Change in Nijmegen-Score [ Time Frame: Between baseline and 3 month follow up ]Questionnare assessing hyperventilation
- Change in Buteyko CP [ Time Frame: Between baseline and 3 month follow up ]Breath hold test
- Spirometry: FEV1 [ Time Frame: Between baseline and 3 month follow up ]FEV1
- Spirometry: FEV1 [ Time Frame: Between baseline and 6 month follow up ]FEV1
- Spirometry: FEV1/VCin [ Time Frame: Between baseline and 3 month follow up ]FEV1/VCin
- Spirometry: FEV1/VCin [ Time Frame: Between baseline and 6 month follow up ]FEV1/VCin
- Spirometry: PEF [ Time Frame: Between baseline and 3 month follow up ]PEF
- Spirometry: PEF [ Time Frame: Between baseline and 6 month follow up ]PEF
- Heart Rate Variability (SDNN) [ Time Frame: Between baseline and 3 month follow up ]SDNN
- Heart Rate Variability (SDNN) [ Time Frame: Between baseline and 6 month follow up ]SDNN
- Heart Rate Variability (RMSSD) [ Time Frame: Between baseline and 3 month follow up ]RMSSD
- Heart Rate Variability (RMSSD) [ Time Frame: Between baseline and 6 month follow up ]RMSSD
- Heart Rate Variability (LF/HF) [ Time Frame: Between baseline and 3 month follow up ]LF/HF
- Heart Rate Variability (LF/HF) [ Time Frame: Between baseline and 6 month follow up ]LF/HF
- Vascular stiffness [ Time Frame: Between baseline and 3 month follow up ]Pulse Wave Velocity
- Vascular stiffness [ Time Frame: Between baseline and 6 month follow up ]Pulse Wave Velocity
- Blood Pressure [ Time Frame: Between baseline and 3 month follow up ]Systolic and Diastolic
- Blood Pressure [ Time Frame: Between baseline and 6 month follow up ]Systolic and Diastolic
- Haemodynamics Stroke volume [ Time Frame: Between baseline and 3 month follow up ]Stroke volume
- Haemodynamics Stroke volume [ Time Frame: Between baseline and 6 month follow up ]Stroke volume
- Haemodynamics Cardiac output [ Time Frame: Between baseline and 3 month follow up ]Cardiac output
- Haemodynamics Cardiac output [ Time Frame: Between baseline and 6 month follow up ]Cardiac output
- Haemodynamics Total Vascular Resistance [ Time Frame: Between baseline and 3 month follow up ]Total Vascular Resistance
- Haemodynamics Total Vascular Resistance [ Time Frame: Between baseline and 6 month follow up ]Total Vascular Resistance
- Haemodynamics Cardiac index [ Time Frame: Between baseline and 3 month follow up ]Cardiac index
- Haemodynamics Cardiac index [ Time Frame: Between baseline and 6 month follow up ]Cardiac index
- Haemodynamics Perfusion [ Time Frame: Between baseline and 3 month follow up ]Perfusion index
- Haemodynamics Perfusion [ Time Frame: Between baseline and 6 month follow up ]Perfusion index
- Haemodynamics Plethvariability [ Time Frame: Between baseline and 3 month follow up ]Plethvariability index (PVI)
- Haemodynamics Plethvariability [ Time Frame: Between baseline and 6 month follow up ]Plethvariability index (PVI)
- Oxygen Saturation [ Time Frame: Between baseline and 3 month follow up ]SpO2
- Oxygen Saturation [ Time Frame: Between baseline and 6 month follow up ]SpO2
- ACQ [ Time Frame: Between baseline and 3 month follow up ]Asthma Control Questionnaire, E. Juniper
- ACQ [ Time Frame: Between baseline and 6 month follow up ]Asthma Control Questionnaire, E. Juniper
- AQLQ [ Time Frame: Between baseline and 3 month follow up ]Asthma Quality of Life Questionnaire, E. Juniper
- AQLQ [ Time Frame: Between baseline and 6 month follow up ]Asthma Quality of Life Questionnaire, E. Juniper
- ARCIM Questionnaire [ Time Frame: Between baseline and 3 month follow up ]Questionnaire focusing on respiratory complaints like mucus, snoring, blocked nose.
- ARCIM Questionnaire [ Time Frame: Between baseline and 6 month follow up ]Questionnaire focusing on respiratory complaints like mucus, snoring, blocked nose.
- STAI Questionnaire [ Time Frame: Between baseline and 3 month follow up ]State and Trait Anxiety Inventory
- STAI Questionnaire [ Time Frame: Between baseline and 6 month follow up ]State and Trait Anxiety Inventory
- ASF Questionnaire [ Time Frame: Between baseline and 3 month follow up ]"Aachener Selbstwirksamkeitsfragebogen"
- ASF Questionnaire [ Time Frame: Between baseline and 6 month follow up ]"Aachener Selbstwirksamkeitsfragebogen"
- Asthma medication [ Time Frame: Between baseline and 3 month follow up ]Kind and dosage of asthma specific medication like steroids or betamimetics
- Asthma medication [ Time Frame: Between baseline and 6 month follow up ]Kind and dosage of asthma specific medication like steroids or betamimetics

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Written informed consent, regular intake of prescribed asthma medication according to the AWMF scheme level 1, native speaker of german
Exclusion Criteria:
- Participation in another study, comorbidities (heart diseases, cancer still under treatment, psychiatric diseases)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03098849
Germany | |
ARCIM Institute | |
Filderstadt, Baden Württemberg, Germany, 70794 |
Responsible Party: | ARCIM Institute Academic Research in Complementary and Integrative Medicine |
ClinicalTrials.gov Identifier: | NCT03098849 |
Other Study ID Numbers: |
RBT_10 |
First Posted: | April 4, 2017 Key Record Dates |
Last Update Posted: | May 9, 2018 |
Last Verified: | May 2018 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Buteyko-based breathing technique training |
Asthma Respiratory Aspiration Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Respiration Disorders Pathologic Processes |